Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vincristine, Etoposide and Cyclosporine A in Concert With Standard Dose Radiation Therapy in Diffuse Intrinsic Brain Stem Glioma - A Phase I Study of Dose Escalation of Vincristine

NCT00003625 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00003625
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003625 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vincristine, Etoposide and Cyclosporine A in Concert With Standard Dose Radiation Therapy in Diffuse Intrinsic Brain Stem Glioma - A Phase I Study of Dose Escalation of Vincristine
Lead sponsor
Children's Oncology Group
Phase
Phase 1
Overall status
Completed
Start date
December 31, 1998
Completion date
April 30, 2006
Enrollment
7 (actual)
Sites
74

Conditions

As the registry lists them; a condition with its own page is linked.

brain tumors, central nervous system tumors